beta
OREX
Orexigen Therapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Orexigen Therapeutics Inc is an emerging pharmaceutical company. The company is developing neuroscience drugs that will ultimately address obesity and weight related medical issues.
Market Cap: 20.8 Million
Primary Exchange: Nasdaq Global Select
Website: http://www.orexigen.com
Shares Outstanding: 18.7 Million
Float: 18.4 Million
Dividend: 0.0 (0.0%)
Beta: 2.048594
Sector: Healthcare
Industry: Drug Manufacturers
Ethical Flags
Longest drawdown: 790 trading days
From: 2015-03-04 To: 2018-04-03
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-07-12 | 10.0 | 1.0 | 10.0 |